-
dhcr7 Knockout Grass Carp Shows GCRV Resistance
2026-08-25
A 2026 Aquaculture Reports study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and demonstrated an approximately 40% survival advantage after GCRV-II challenge. The work provides in vivo evidence that a cholesterol-biosynthesis enzyme can influence antiviral immunity without compromising growth or muscle morphology.
-
Bovine Liver Organoids Model Dairy Cow Fatty Liver
2026-08-24
Lei et al. developed a bovine liver organoid system that reproduces key features of fatty liver disease in high-yielding dairy cows, including triglyceride and cholesterol accumulation after fatty-acid exposure. The model also enabled preliminary evaluation of natural compounds and atorvastatin, offering a species-relevant platform for disease mechanism studies and therapeutic screening while reducing reliance on live-animal experiments.
-
STMN2 Loss in ALS: Translation and Stress Granules
2026-08-23
This study identifies TDP-43-independent mechanisms that rapidly deplete the neuronal protein STMN2 during cellular stress, linking proteasomal degradation, phosphorylation, translation repression, and stress granules. Its findings suggest that baseline STMN2 abundance and regional RNA compensation may influence neuronal vulnerability in amyotrophic lateral sclerosis (ALS), while providing a framework for longitudinal stress and survival experiments.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-08-22
Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 supports detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is intended for controlled research workflows only, not diagnostic or therapeutic use, and assay performance should be confirmed in the investigator’s sample matrix.
-
Muscle BDNF and Early Neuromuscular Synapse Formation
2026-08-21
This study identifies podosome-like structures as spatial control sites for muscle-derived BDNF trafficking and calcium-dependent release during the earliest stages of neuromuscular junction development. By combining live imaging, BDNF loss-of-function, furin inhibition, agrin or nerve stimulation, and muscle-specific knockout mice, the authors connect localized BDNF processing to aneural and synaptic acetylcholine receptor cluster formation.
-
Separating Growth Arrest from Cell Death in Cancer
2026-08-21
Hannah R. Schwartz’s dissertation identifies a key interpretive problem in in vitro oncology: relative viability and fractional viability are often treated as interchangeable even though they capture different components of drug response. Its framework shows that drugs can influence proliferation and cell death in different proportions and on different timelines, supporting more discriminating experimental design and analysis.
-
Caveolin-1, Cholesterol, and MASLD Progression
2026-08-20
The reference study identifies caveolin-1 as a regulator of hepatic cholesterol homeostasis that limits endoplasmic reticulum stress and pyroptosis during metabolic dysfunction-associated steatotic liver disease. By integrating a CAV1-deficient mouse model, liver transcriptomics, human samples, and in vitro experiments, the work connects the FXR/NR1H4–ABCG5/ABCG8 axis with disease progression and provides a mechanistic framework for studying cholesterol-driven liver injury.
-
BCECF-AM for Plant Autophagy pH Assays
2026-08-20
BCECF-AM converts intracellular acid–base changes into a quantitative ratiometric readout, making it a practical complement to genetic and imaging assays of Arabidopsis autophagy. This guide connects vacuolar acidification biology with executable dye-loading, calibration, imaging, and troubleshooting workflows.
-
Atrial Natriuretic Peptide: Research Workflows
2026-08-19
Build more reproducible ANP experiments for vascular, renal, and adipose models with practical preparation, dosing, controls, and troubleshooting guidance. The workflow also shows how the reference study’s mechanistic design can strengthen cardiovascular disease research without confusing adiponectin findings with ANP biology.
-
Neomycin Sulfate: Mechanisms and Research Uses
2026-08-19
Neomycin sulfate is an aminoglycoside antibiotic used as a molecular probe for RNA/DNA structure interaction studies and ion-channel mechanisms. Its reported activities include inhibition of hammerhead ribozyme cleavage, disruption of HIV-1 Tat–TAR binding, DNA triplex structure stabilization, and voltage-dependent ryanodine receptor channel block.
-
Tomivosertib as a Translational MNK1 Inhibitor
2026-08-18
Tomivosertib is a selective MNK1 inhibitor that connects eIF4E phosphorylation with glioblastoma growth, angiogenesis, and chemotherapy response. This article develops an evidence-driven assay framework for distinguishing target engagement, tumor-cell effects, endothelial effects, and treatment sensitization.
-
HIV-1 Nuclear Pores License Resting T-Cell Infection
2026-08-18
The reference study identifies nuclear pore complex remodeling as the bottleneck that normally restricts HIV-1 infection of resting CD4+ T cells. It shows that cell–cell spread activates CD4–LCK–CDK1 signaling, modifies nucleoporins, and enables capsid nuclear import without requiring entry into the cell cycle.
-
Talabostat Mesylate: FAP Assay Workflows
2026-08-17
Talabostat mesylate, also known as PT-100, gives researchers a practical pharmacological handle on DPP4 and FAP activity in tumor and immune models. This guide translates that inhibition into cell-based assays, tumor microenvironment studies, cytokine workflows, and mechanistic controls inspired by a pericyte-targeting vascular-disruption study.
-
Low-Molecular Weight Inhibitors of the Alternative Pathway
2026-08-16
Schubart and colleagues review how factor B and factor D became tractable targets for selective, orally available inhibition of the alternative complement pathway. The article connects pathway biochemistry, medicinal-chemistry challenges, disease genetics, and translational development, providing a framework for interpreting factor B inhibition in complement activation research.
-
ECL Chemiluminescent Substrate Detection Kit for AMPK
2026-08-15
Use high-sensitivity ECL to resolve low-abundance pathway proteins in microbiome–cancer studies, from UHRF1 and AMPK validation to multiplexed western blot workflows. The enhanced formulation combines low-picogram detection, extended luminescence, and compatibility with film, CCD, and laser imaging for flexible protein immunodetection.